Delivery Order SPE2DB24D1021-SPE2DB24FEUAD

Award Date 9/10/24
Potential Completion Date 10/1/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 75 mg tablets. The contract has a ceiling value of $10,852.00 and was awarded on July 17, 2024, with an ultimate completion date of August 7, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a $23,983.26 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of PROMACTA 25 MG TABLET, a specialty medication, with a period of performance through August 2024. The contract is a firm fixed-price arrangement and does not have a small business set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product. The award is not associated with a set-aside program and has a ceiling value of $23,983.26. The contract is a Firm Fixed Price delivery order with an ultimate completion date of October 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROMACTA 25 MG TABLET, a pharmaceutical product, with a ceiling value of $4,418.06 and a period of performance through March 20, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $13,251.75 firm-fixed-price delivery order is for the supply of PROMACTA 12.5 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.89 firm fixed-price contract is for the supply of PROMACTA 50 MG TABLET, a specialty medication, to support DLA Troop Support Medical's procurement of pharmaceutical products for military healthcare programs. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,242.58, is for the delivery of 4564186192 PROMACTA 50 MG TABLET UU 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 50 MG TABLET. The contract has a firm fixed price of $7,242.58 and an ultimate completion date of July 22, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,418.06, is for the supply of PROMACTA 25 MG TABLET and has a performance period through March 17, 2025. The contract is a firm-fixed price delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of PROMACTA 50 mg tablets and has a ceiling value of $43,455.48. It is a firm-fixed price contract with a period of performance through November 8, 2024. The contract has no set-aside designation, indicating it was open to competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FEUAD
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 25 MG TABLET in 30-count units. The contract is a Firm Fixed Price (FFP) arrangement with a ceiling value of $3,997.21 and a period of performance through October 1, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order is not designated as a set-aside contract.

Generated 12/10/24, 2:31 PM